The Neuromuscular Center operates several programs including:
EMG Laboratory Program
When an electromyelogram (EMG) is required, the test needs to be properly done by specialists who have the experience and skill to deliver precise results. EMGs are highly technical tests that greatly depend on the expertise of those performing them for accurate results. Data that is incorrectly collected or interpreted can lead to unnecessary repeat testing or even improper treatment. The EMG laboratory, headed by Dr. Bashar Katirji, conducts these tests with a staff of physicians who are nationally recognized and respected. They have written and edited numerous books and book chapters on EMG. The lab’s nerve conduction study technologists must be registered and certified by the American Association of Electrodiagnostic Technologists, a radical departure from the requirements of most other EMG labs that results in more accurate results.
Autonomic Lab Program
The Autonomic laboratory, headed by Dr. Thomas C. Chelimsky, is one of the oldest established laboratory in the United States. It is equipped to test all aspects of autonomic function including cardiac, vasomotor and sudomotor (sweat) functions. Patients tested in this lab have a variety of dysautonomia (disorders of autonomic nervous system function) including syncope, orthostatic hypotension, tachycardia, small fiber neuropathy and parkinsonism.
Muscle Disease Program
The Muscle Disease Program, established at UH in 1954, is dedicated to the diagnosis and management of chronic inherited neuromuscular disorders such as muscular dystrophies and Charcot-Marie-Tooth disease. The Program, co-sponsored by United Way, is aimed at accurate diagnosis, and physical rehabilitation of these patients.
ALS Program
This nationally known program takes an interdisciplinary approach to the diagnosis and management of ALS. Specialists from the Neuromuscular Center, Pulmonary Medicine, Speech Pathology and Nutrition participate actively. The promising new treatment of diaphragmatic stimulation and pacing is an integral part of the management of respiratory failure in people with ALS.
Myasthenia Gravis Program
This program, established in 1990, is the only such program in Ohio. Here, patients are often treated with immunosuppressive drugs as well as plasma exchange and intravenous immunoglobulin.